VC-backed AbCellera seeks up to C$500m from IPO: Reuters
Vancouver-based antibody developer AbCellera Biologics said it expects to raise up to C$500 million (US$391 million) in its initial public offering on Nasdaq, Reuters reported.
7 December 2020•1 min read
